ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLRB Cellectar Biosciences Inc

3.32
0.23 (7.44%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cellectar Biosciences Inc CLRB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.23 7.44% 3.32 10:00:00
Open Price Low Price High Price Close Price Previous Close
3.10 3.08 3.33 3.16 3.09
more quote information »

Recent News

Date Time Source Heading
27/3/202421:40GLOBECellectar Biosciences Reports Financial Results for Year..
20/3/202421:40GLOBECellectar Biosciences to Announce 2023 Year End Earnings..
14/3/202423:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
04/3/202422:40GLOBECellectar Biosciences Reports High Rate of Complete..
15/2/202412:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202408:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
02/2/202422:03EDGAR2Form 8-K - Current report
01/2/202400:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/1/202422:40GLOBECellectar Biosciences Announces Enrollment of the First..
26/1/202408:30EDGAR2Form 8-K - Current report
25/1/202422:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
22/1/202422:40GLOBECellectar Biosciences Reports Complete Central Nervous..
16/1/202422:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
12/1/202422:44GLOBECellectar Biosciences to Host Conference Call with Texas..
11/1/202422:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
09/1/202422:02EDGAR2Form 8-K - Current report
08/1/202422:30GLOBECellectar Biosciences Announces Positive Topline Data..
04/1/202400:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
20/12/202300:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
13/12/202312:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202312:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202312:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202312:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202300:30GLOBECellectar Biosciences Strengthens Intellectual Property..
06/12/202300:30GLOBECellectar Biosciences to Present at the Targeted..
30/11/202308:31EDGAR2Form 8-K - Current report
13/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:45EDGAR2Form 8-K - Current report
31/10/202315:15EDGAR2Form EFFECT - Notice of Effectiveness
28/10/202307:40EDGAR2Form 8-K - Current report
26/10/202307:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
06/10/202307:45EDGAR2Form S-3 - Registration statement under Securities Act of..
03/10/202307:40EDGAR2Form DEF 14A - Other definitive proxy statements
23/9/202306:40EDGAR2Form PRE 14A - Other preliminary proxy statements
09/9/202307:17EDGAR2Form 8-K - Current report
22/8/202306:30EDGAR2Form 8-K - Current report
14/8/202322:45EDGAR2Form 8-K - Current report
14/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/6/202306:31EDGAR2Form 8-K - Current report
29/6/202320:03EDGAR2Form 8-K - Current report
29/6/202308:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202308:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock